HCV Test and Treat Utilizing Simplified HCV Patient Education
Reason given: The funding was halted.
Key facts
- Where
- Long Island City and New York, United StatesSee the 3 sites
- Phase
- Phase 4
Where in United States
- Phoenix HouseLong Island City, United StatesNo longer taking part
- ColumbiaDoctors MidtownNew York, United StatesNo longer taking part
- Weill Cornell Medicine Midtown Center for Treatment and ResearchNew York, United StatesNo longer taking part
Trial details
- Who runs it
- Weill Medical College of Cornell University
- Trial code
- NCT05582681
- Record updated
- 27 February 2025
- Original description
The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.Read full original descriptionShow less
The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.
Inclusion: Men and women age greater or equal to18 at study entry or emancipated minors over greater or equal to 16 to less or equal 70 years at study entry; HCV antibody positive; HCV treatment naïve (no prior treatment with an approved or investigational anti HCV medication).
Exclusion: Current or history of decompensated liver disease (including but not limited to encephalopathy, variceal bleeding, or ascites) prior to study entry; History of hepatocellular carcinoma (HCC); Any history of active Hepatitis B or positive HBsAg positive test; HCV RNA undetectable.